Who are Disc Medicine's investors?

Disc Medicine's investors include Access Biotechnology, Atlas Venture, Bain Capital Life Sciences, Foresite Capital, Frazier Life Sciences, OrbiMed, 5AM Ventures, Alexandria and 5 more.

Disc Medicine

NASDAQ: IRON

170 employees on LinkedIn · 14 known investors

Find your way into Disc Medicine

1,213 people in our graph share verified history with the Disc Medicine team — schools, employers, funds. One of them is your warm intro.

Nick Roelofsunlockedknows Lisa Amaya Price · together at LGC (overlapped)

×2knows the team · via Scholar Rock

knows the team · via Disc Medicine

knows the team · via Nektar Therapeutics

knows the team · via Weber Shandwick

×6knows the team · via Amgen

Disc Medicine is a biopharmaceutical company developing therapies from discovery through clinical development for patients in need. It is led by a team of scientists and industry veterans across chemistry, clinical development, and medical affairs.

Biotech Healthtech

Founders & leadership

John QuiselChief Executive Officer

Jean Franchi Chief Financial OfficerJean Franchi is Chief Financial Officer of Disc Medicine and has over 30 years of experience in life sciences finance and operations across biotech, diagnostics, and medical device companies at stages ranging from pre-clinical to commercial. He holds board positions at multiple life sciences companies including Biodesix, Flamingo Therapeutics, and VectorY Therapeutics.

Jonathan YuChief Operating Officer

Will SavageChief Medical Officer

Pamela Stephenson Chief Commercial OfficerShe has held leadership roles in biotech and pharmaceutical companies, with background in product launches and brand marketing.

Steve CafféChief Regulatory Officer

Rahul Rajan Kaushik Chief Technical OfficerRahul Rajan Kaushik holds a Ph.D. from Stanford University in chemistry and cell biology, and brings over 20 years of experience in pharmaceutical process development, analytical development, manufacturing, and commercialization across antibodies, small molecules, and protein conjugates. At Disc Medicine, he serves as Chief Technical Officer leading cross-functional teams through regulatory submissions and commercial launch.

Rahul KharaChief Legal Officer

Lisa Amaya Price Chief Human Resources OfficerShe brings over 20 years of human resources experience across multiple fast-growth industries.

Hua YangChief Early Development Officer

Investors · 14

Access Biotechnologylisted by Access BiotechnologyNew York

How we know: Access Biotechnology's portfolio page · globalgenes.org · Not right? Tell us

Atlas Venturelisted by Atlas VentureCambridge · $500K – $1M

How we know: Atlas Venture's portfolio page · globalgenes.org · the VCSheet dataset · Not right? Tell us

Bain Capital Life Scienceslisted by Bain Capital Life SciencesBoston

How we know: Bain Capital Life Sciences's portfolio page · Not right? Tell us

Foresite Capitallisted by Foresite CapitalWest Hollywood

How we know: Foresite Capital's portfolio page · Not right? Tell us

Frazier Life Scienceslisted by Frazier Life SciencesPalo Alto

How we know: Frazier Life Sciences's portfolio page · Not right? Tell us

OrbiMedlisted by OrbiMedNew York · $1M – $75M

How we know: OrbiMed's portfolio page · a partner's Signal profile · globalgenes.org · the VCSheet dataset · Not right? Tell us

5AM VenturesreportedSan Francisco · $100K – $4M

How we know: globalgenes.org · Not right? Tell us

AlexandriareportedPasadena

How we know: globalgenes.org · Not right? Tell us

Arix BiosciencereportedLondon

How we know: globalgenes.org · Not right? Tell us

Janus Henderson InvestorsreportedLondon

How we know: globalgenes.org · Not right? Tell us

Novo HoldingsreportedCopenhagen · $1.1M – $54M

How we know: globalgenes.org · Not right? Tell us

Rock Springs CapitalreportedBaltimore

How we know: globalgenes.org · Not right? Tell us

Willett AdvisorsreportedNew York

How we know: globalgenes.org · Not right? Tell us

Also in the syndicate · 1

Nantahala Capital Management

Funding

SEC filings, press & company announcements

Undisclosed amountseries BSep 2021
OrbiMed (lead), 5AM Ventures, Access Biotechnology, Alexandria Venture Investments, Arix Bioscience, Atlas Venture, Janus Henderson Investors, Nantahala Capital Management, Novo Holdings, Rock Springs Capital, Willett Advisors
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through Disc Medicine went on to found or lead other companies.

Kevin BittermanBoard Of DirectorsFounded Editas Medicine Nadim AhmedBoard DirectorFounded Cullinan Therapeutics

Competitors · 3

by search overlap

Bioworld30 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Seeking Alpha26 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.

Eli Lilly26 shared keywordsEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.

Companies competing with Disc Medicine for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Disc Medicine do?: Disc Medicine is a biopharmaceutical company developing therapies from discovery through clinical development for patients in need. It is led by a team of scientists and industry veterans across chemistry, clinical development, and medical affairs.
Who are Disc Medicine's investors?: Disc Medicine's investors include Access Biotechnology, Atlas Venture, Bain Capital Life Sciences, Foresite Capital, Frazier Life Sciences, OrbiMed, 5AM Ventures, Alexandria and 5 more.